SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-19-000551
Filing Date
2019-02-14
Accepted
2019-02-14 07:53:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT arrowmark-atra123118a2.htm SC 13G/A 52617
  Complete submission text file 0001172661-19-000551.txt   54263
Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

IRS No.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 19600819
SIC: 2836 Biological Products, (No Diagnostic Substances)